Convalescent Plasma of Covid-19 to Treat SARS-COV-2 a Randomized Doble Blind 2 Center Trial
Clinical trial NCT04405310 · COMPLETED
Trial details
- NCT number
- NCT04405310
- Sponsor
- Grupo Mexicano para el Estudio de la Medicina Intensiva
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-20
- Primary completion
- 2020-11-20
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.